Jump to navigation Jump to search

Template:Chembox new

WikiDoc Resources for Oligomycin


Most recent articles on Oligomycin

Most cited articles on Oligomycin

Review articles on Oligomycin

Articles on Oligomycin in N Eng J Med, Lancet, BMJ


Powerpoint slides on Oligomycin

Images of Oligomycin

Photos of Oligomycin

Podcasts & MP3s on Oligomycin

Videos on Oligomycin

Evidence Based Medicine

Cochrane Collaboration on Oligomycin

Bandolier on Oligomycin

TRIP on Oligomycin

Clinical Trials

Ongoing Trials on Oligomycin at Clinical Trials.gov

Trial results on Oligomycin

Clinical Trials on Oligomycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oligomycin

NICE Guidance on Oligomycin


FDA on Oligomycin

CDC on Oligomycin


Books on Oligomycin


Oligomycin in the news

Be alerted to news on Oligomycin

News trends on Oligomycin


Blogs on Oligomycin


Definitions of Oligomycin

Patient Resources / Community

Patient resources on Oligomycin

Discussion groups on Oligomycin

Patient Handouts on Oligomycin

Directions to Hospitals Treating Oligomycin

Risk calculators and risk factors for Oligomycin

Healthcare Provider Resources

Symptoms of Oligomycin

Causes & Risk Factors for Oligomycin

Diagnostic studies for Oligomycin

Treatment of Oligomycin

Continuing Medical Education (CME)

CME Programs on Oligomycin


Oligomycin en Espanol

Oligomycin en Francais


Oligomycin in the Marketplace

Patents on Oligomycin

Experimental / Informatics

List of terms related to Oligomycin

Oligomycins are macrolides created by Streptomyces that can be poisonous to other organisms.


They have use as antibiotics.

In addition, oligimycin inhibits ATP synthase by blocking its proton channel, which is necessary for oxidative phosphorylation of ADP to ATP (energy production).

Administering oligomycin to an individual can result in very high levels of lactate accumulating in the blood and urine.[citation needed]

hu:Oligomicin Template:WH Template:WikiDoc Sources